|
L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Suppliers list
|
L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- manufacturers
- Clezutoclax
-
-
2026-05-11
- CAS:1949843-71-3
- Purity:
- Supply Ability: 10g
|
| | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Basic information |
| Product Name: | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- | | Synonyms: | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy-;Clezutoclax | | CAS: | 1949843-71-3 | | MF: | C83H102N12O24S2 | | MW: | 1715.9 | | EINECS: | | | Product Categories: | | | Mol File: | 1949843-71-3.mol | ![L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Structure](CAS/20240320/GIF/1949843-71-3.gif) |
| | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Chemical Properties |
| density | 1.55±0.1 g/cm3(Predicted) | | pka | 1.27±0.50(Predicted) |
| | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Usage And Synthesis |
| Uses | Clezutoclax is aagent-linker conjugate for ADC. Clezutoclax can be used in the synthesis of antibody-drug conjugates (ADCs)[1]. | | References | [1] Boni V, et al. The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-17. DOI:10.1200/EDBK_281107 |
| | L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy- Preparation Products And Raw materials |
|
|
Tag:L-glycero-L-gulo-Octonic acid, 2,6-anhydro-8-[2-[[[[[2-[[3-[[4-[6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-2-carboxy-3-pyridinyl]-5-methyl-1H-pyrazol-1-yl]methyl]-5,7-dimethyltricyclo[3.3.1.13,7]dec-1-yl]oxy]ethyl][(3S)-3,4-dihydroxybutyl]amino]carbonyl]oxy]methyl]-5-[[N-[2-[(3S,5S)-3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-2-oxo-5-[(2-sulfoethoxy)methyl]-1-pyrrolidinyl]acetyl]-L-valyl-L-alanyl]amino]phenyl]-7,8-dideoxy-(1949843-71-3)
Related Product Information
|